Medical Device News Magazine

Vizient Medical Device Tech Watch Highlights Rapid Adoption of AI-Enabled Stroke Detection

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Data analysis from the Vizient, Inc. Clinical Data Base shows a rapid uptake in the use of artificial intelligence (AI) for detection of ischemic stroke. The data is highlighted in the latest edition of Vizient’s Medical Device Tech Watch. In addition, the publication offers insights on the shift of spine and orthopedics from hospital inpatient to ambulatory surgery centers as well as a perspective on improving surgical preference card management. The publication can be accessed here.

“This year has brought about many opportunities to partner strategically and collaborate across organizations to tackle obstacles in health care,” said Erik Axter, managing principal, physician preference, Vizient. “We are excited about the new technologies and solutions emerging to help solve these challenges and advance our industry, particularly in complex categories like cardiology and orthopedics.”

Featured articles include:

AI-enabled ischemic stroke detection, triage and notification—Quick intervention for an intracranial large-vessel occlusion (LVO), a common type of ischemic stroke, can improve patient outcomes. With the AI process, an interventionalist could conceivably receive the LVO image on their mobile phone, evaluate the scan and begin booking the procedure immediately. On October 1, 2020, the Centers for Medicare & Medicaid Services (CMS) implemented a reimbursement policy for AI-based LVO detection. By the first quarter of 2021, analysis of the Vizient Clinical Data Base showed, the number of Vizient members using the AI technology doubled.

The shift to ambulatory orthopedic and spine procedures moves suppliers to ramp up provider support—ASC procedural volume continues to accelerate, fueled by CMS policy changes, commercial payer steerage, patient preference and pressure to reduce costs. Data from Sg2, a Vizient company, predicts outpatient hip and knee replacements to increase by 75% over the next several years. Manufacturers are responding to the current and future growth by expanding their service line and technology offerings to support ASC performance.

How one health system improved supply availability and accuracy by optimizing their surgical preference card database—Inaccurate surgical preference cards were negatively affecting surgeon and staff satisfaction and slowing turnaround times in the OR of a large academic medical. To address this issue, they developed a sustainable process for managing the cards, increasing staff confidence in their accuracy and ensuring the OR is properly equipped prior to each procedure, improving efficiency as well as patient safety.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”